NewGenne Ltd
Solution Type
Microbial Management, Antimicrobial Stewardship, Antimicrobial Compound
Pathogens Addressed
Bacteria, Fungi, Viruses, Yeasts
Sectors Served
Human Health, Veterinary, AgriFood, Environmental
Overview
NewGenne is a Cambridge-based biotechnology company developing novel antibiotics using synthetic biology and metabolic engineering to produce next-generation natural product-derived antimicrobials. Its platform applies advanced gene-cluster mining and pathway engineering to discover and optimize bacterial natural products with activity against drug-resistant pathogens, targeting compound classes with new mechanisms of action not represented in the current antibiotic pipeline.
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
